Genetic predisposition to severe sepsis

Clinical Pulmonary Medicine

Volumn 9, Issue 4, 2002, Pages 229-237

  Chiche, Jean Daniel ^a   Pingat, Juliette ^a   Cariou, Alain ^a   Mira, Jean Paul ^a  

^a Réanimation Médicale ^*  (France)

Author keywords

Genetics; Infection; Innate immunity; Polymorphism; Susceptibility

Indexed keywords

CD14 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LECTIN; MANNOSE BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE RELEASE; DNA POLYMORPHISM; GENETIC PREDISPOSITION; GENOMICS; HEREDITY; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; MENINGOCOCCOSIS; MUTATION; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT INFECTION; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 0036061992     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-200207000-00006     Document Type: Review

References (103)

1. Susceptibility to critical illness: Reserve, response and therapy
2. The immunogenetics of human infectious diseases
3. Defective LPS signaling in C3H/HeJ and C57BL/10ScCR mice: Mutations in TLR4 gene
4. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection
5. Disseminated tuberculosis in IFN-γ gene disrupted mice
6. Mice that lack the IFN-γ receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide
7. Interleukin 12 is crucial to development protective immunity mice intravenously infected with mycobacterium tuberculosis
8. Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene?
9. Interferon-gamma receptor deficiency in infant with fatal Bacille Calmette-Guerin infection
10. Severe mycobacterial Salmonella infections in interleukin-12 receptor-deficient patients
11. A human IFN-γR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
12. Tuberculosis in twins: A reanalysis of the Prophit survey
13. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis: An epidemiological perspective
14. Hepatitis B virus markers in Chinese twins
15. Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro
16. Helicobacter pylori infection: Genetic and environmental influences. A study of twins
17. Genetic and environmental influences on premature death in adult adoptees
18. Primary immunodeficiency diseases due to defects in lymphocytes
19. Immunodeficiency diseases caused by defects in phagocytes
20. Evaluation of the patient with recurrent bacterial infections
21. Cystic fibrosis: An inherited susceptibility to bacterial respiratory infections
22. Modifier genes convert "simple" Mendelian disorders to complex traits
23. Genetic epidemiology
24. Genetic dissection of complex traits
25. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
26. Population choice in mapping genes for complex diseases
27. Innate immunity: Impact on the adaptive immune response
28. Innate immunity
29. Innate immune induction of the adaptive immune response
30. Genetic heterogeneity of mannose-binding proteins: The Jekyll and Hyde of innate immunity?
31. Membrane receptors for soluble collagens
32. Mannose-binding lectin: The pluripotent molecule of the innate immune system
33. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
34. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
35. Mannose-binding lectin alleles in a prospectively recruited UK population: The ALSPAC Study Team
36. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
37. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease
38. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood
39. Clinical relevance of Fcg receptor polymorphisms
40. Selective IgG subclass deficiency: Quantification and clinical relevance
41. Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia
42. Association of human FcγRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease
43. The inflammatory balance in human sepsis
44. Proinflammatory cytokines
45. Cytokine gene polymorphism in human disease: On-line databases
46. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
47. Tumor necrosis factor: Biology and therapeutic inhibitors
48. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice
49. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans
50. Circulating endothelin-1 and tumor necrosis factor-a: Early predictors of morality in patients with septic shock
51. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences
52. TNF-α gene polymorphism: Clinical and biological implications
53. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
54. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
55. A polymorphism than affects OCT-1 binding to the TNF promoter region is associated with severe malaria
56. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
57. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease
58. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniosis
59. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha gene promoter and with elevated TNF-α levels in tear fluids
60. Tumor necrosis factor-alpha promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients
61. High-producer allele of tumor necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-induced nephropathia epidemica
62. Variation in the tumor necrosis factor alpha gene promoter region may be associated with death from meningococcal disease
63. Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis
64. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study
65. Tumor necrosis factor gene polymorphism and septic shock in surgical infection
66. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter
67. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus
68. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis
69. Relation of a TNF gene polymorphism to severe sepsis in trauma patients
70. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation
71. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation
72. The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1
73. Functions of interleukin 1 receptor antagonist in gene knock out and overproducing mice
74. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
75. A Taq1 polymorphism in the human interleukin-1β gene correlates with IL-1β secretion in vitro
76. Presence of the IL-RA allele 2 is associated with enhanced IL-1b production in vitro
77. Comparison of two polymorphisms of the interleukin-1 gene family. Intereleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis
78. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
79. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
80. Sir Isaac Newton, sepsis, SIRS and CARS
81. Genetic influence on cytokine production and fatal meningococcal disease
82. Anti-inflammatory cytokine profile and mortality in febrile patients
83. Interleukin 10 secretion in relation to human IL-10 locus haplotypes
84. Gene polymorphisms of interleukins 1 and 10 in infections and autoimmune diseases
85. Novel single nucleotide polymorphisms in the distal Il-10 promoter affect Il-10 production and enhance the risk of systemic lupus erythematosus
86. An investigation of polymorphism in the interleukin-10 gene promoter
87. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis endemic population
88. Polymorphism of the interleukin-10 gene is associated with high susceptibility to Epstein-Barr virus infection
89. Coagulation abnormalities in acute lung injury and sepsis
90. Increase of plasminogen activator inhibitor levels predicts outcome of patients with sepsis
91. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock
92. Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal septic shock
93. Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients
94. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease
95. Initial sequencing and analysis of the human genome
96. The sequence of the human genome
97. Resequencing and mutational analysis using oligonucleotide microarrays
98. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations
99. The common functional C(-159)T polymorphism within the promoter region of the lipopoly-saccharide receptor CD14 is not associated with sepsis development or mortality
100. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis
101. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
102. Relevance of mutations in the TLR4 receptor in patients with Gram negative septic shock
103. Host genetic influences on HIV-1 pathogenesis